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Toll-like receptors (TLRs) play a key role in the innate immune response by sensing 2 
bacterial ligands. The mechanisms involved in the TLR-mediated cytokine response are 3 
well established, however, the possible contribution of TLR-dependent recognition of 4 
bacteria to macrophage phagocytosis remains unclear. Listeria monocytogenes (LM) is 5 
an intracellular parasitic Gram-positive bacterium recognized mainly by TLR2. In this 6 
study, we investigated whether TLR2-dependent signaling is involved in the 7 
phagocytosis of LM by macrophages. We found no difference in the number of LM 8 
associating with wild type (WT) and TLR2–/– macrophages 1 h after infection. However, 9 
the number of LM phagocytosed in TLR2–/– and MyD88–/– macrophages was 10 
significantly lower compared with WT macrophages. In addition, LPS treatment 11 
restored impaired phagocytic activity of TLR2–/– macrophages but did not enhance the 12 
activity of MyD88–/– macrophages. The efficiency of phagocytosis was suppressed by 13 
inhibitors of phosphatidylinositol 3-kinase (PI3K) and the small Rho GTPases, but not 14 
by cycloheximide. Moreover, functional activation of PI3K and Rac1 was impaired in 15 
TLR2–/– and MyD88–/– macrophages. In an in vivo infection model, we found 16 
significantly lower numbers of LM phagocytosed in peritoneal macrophages of TLR2–/– 17 
and MyD88–/– mice after intraperitoneal infection. Moreover, a lower number of bacteria 18 
were detected in the spleen of TLR2–/– mice 1 day after intravenous infection compared 19 
with WT mice. These results clearly indicated that TLR2-MyD88-dependent signaling 20 
enhances the basal level of phagocytosis of LM by macrophages through activation of 21 
PI3K and Rac1, not by synthesis of proinflammatory cytokines or expression of 22 




Listeria monocytogenes (LM) is a Gram-positive facultative intracellular bacterium that 2 
causes severe disease (listeriosis) in humans and various animal species with a mortality 3 
rate of approximately 30% (14, 38). LM can invade various types of cells including 4 
epithelial cells, hepatocytes, endothelial cells, fibroblasts and macrophages. After entry 5 
into host cells, LM is trapped temporarily in an endosome. However, the bacterium 6 
quickly escapes from the endosome into the cell cytoplasm where it undergoes rapid 7 
replication by means of expressing various virulence genes including prfA, plcA, hlyA, 8 
actA, mpl and plcB, all of which are located in a locus called Listeria pathogenicity 9 
island 1 (14). 10 
Accumulating evidence suggests that LM gains entry into nonprofessional phagocytes 11 
by utilizing bacterial invasion factors called internalins (11, 20, 24, 34, 42, 46). Indeed, 12 
internalin A mediates the entry of LM into human intestinal cells through binding to E-13 
cadherin and the interaction of internalin B with c-Met (hepatocyte growth factor 14 
receptor) induces endocytosis of the bacterium into various types of cells (8, 25, 37). In 15 
comparison, professional phagocytes such as macrophages are able to phagocytose and 16 
subsequently kill various pathogens through phagolysosome fusion. Macrophages are 17 
known to express various receptors that recognize bacterial components or bind to 18 
opsonins attached to bacteria (54), a series of intracellular signaling pathways are then 19 
activated that lead to the dynamic and rapid reorganization of the actin cytoskeleton for 20 
phagocytic engulfment. Of these receptors, Fcγ receptor and complement receptor serve 21 
as opsonin receptors for IgG and C3b, respectively, that bind to the surface of bacteria 22 
(19, 33). Mannose receptor and CD14 can contribute to phagocytosis of bacteria 23 
through direct binding to mannosylated components (15, 17, 45). Scavenger receptor is 24 
 4 
also implicated in phagocytosis (43). These different cell surface receptors likely 1 
operate alone or in combination in the recognition and efficient internalization of 2 
bacteria into macrophages.  3 
 4 
Toll-like receptors (TLRs) are type I integral membrane glycoproteins that are 5 
expressed in all lymphoid tissues with the highest expression in peripheral blood 6 
leukocytes. TLRs are pattern recognition receptors (PRR) characterized by the presence 7 
of a Toll/IL-1 receptor (TIR) domain homologous to interleukin-1 receptor (IL-1R) in 8 
their cytoplasmic portion and a variable number of leucine-rich repeats (LRR) in their 9 
extracellular portion (31). There are more than ten TLRs identified to date in mammals, 10 
and each TLR exhibits a distinct function in innate immune recognition (1, 5, 52). For 11 
example, TLR2 recognizes lipoteichoic acid, peptidoglycan and lipoproteins of Gram-12 
positive bacteria. TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative 13 
bacteria and TLR9 recognizes bacterial hypomethylated CpG DNA motifs. TLR-14 
dependent recognition of bacteria induces a signal through myeloid differentiation 15 
factor 88 (MyD88) and is accompanied by inflammatory responses in macrophages (51). 16 
TLR2-MyD88 signaling is known to be critical for the pro-inflammatory cytokine 17 
response during LM infection. Several studies in vivo have revealed that TLR2 is 18 
required for optimum control of LM infection (29, 53). The increased susceptibility of 19 
MyD88–/– mice to LM infection may support the idea that TLR2 plays a role in 20 
resistance to LM (47). On the other hand, Edelson et al. showed that MyD88 was 21 
necessary for resistance to LM infection but TLR2 deficiency did not influence the 22 
propagation of LM in vivo (16). These conflicting findings appeared to indicate that 23 
though TLR2 participates in host resistance to LM through the induction of cytokine 24 
 5 
production in vivo, there are some signaling pathways that compensate the lack of TLR2 1 
to control bacterial infection.  2 
 3 
In addition to this established function of TLRs in the host cytokine response, recent 4 
studies suggested that TLR signaling modulates the phagocytosis of pathogens (27, 41). 5 
Indeed, Blander and Medzhitov (6) reported that TLR-mediated signaling regulates 6 
phagolysosomal maturation in bone-marrow-derived macrophages after infection with 7 
Escherichia coli, heat-killed Salmonella Typhimurium and Staphylococcus aureus. 8 
Letiembre et al. (35) reported that TLR2 promotes the phagocytosis of Streptococcus 9 
pneumoniae and killing of bacteria by polymorphonuclear leukocytes. Moreover, Luther 10 
et al. (39) have shown that TLR2, MyD88 and dectin-1 are required for efficient 11 
phagocytosis of Aspergillus fumigatus conidia. Doyle et al. (13) also reported that TLR-12 
mediated enhancement of phagocytosis is due to the up-regulation of scavenger 13 
receptors, and another recent report on MyD88-mediated phagocytosis of Borrelia 14 
burgdoferi has emphasized the importance of downstream signaling through PI3K (48). 15 
From these findings it is likely that TLR signaling contributes to the phagocytosis and 16 
phagolysosome formation in professional phagocytes upon infection with extracellular 17 
parasitic bacteria or killed bacteria. On the other hand, little is known about whether the 18 
phagocytosis of LM, a representative Gram-positive intracellular parasitic bacterium, is 19 
dependent on the TLR signaling pathway. In this study, we analyze the contribution of 20 
TLR2-MyD88 signaling to phagocytosis of LM both in vitro and in vivo.  21 
 22 
Materials and Methods 23 
Reagents 24 
 6 
Lipopolysaccharide (LPS) and Clostridium difficile toxin B, a small Rho GTPase 1 
inhibitor, were purchased from Sigma-Aldrich (Tokyo, Japan). Pam3CSK4 was 2 
purchased from Invivogen (San Diego, CA, USA). LY294002, a phosphatidylinositol 3-3 
kinase (PI3K) inhibitor, was obtained from Calbiochem (Tokyo, Japan). Gentamicin 4 
was purchased from Wako Pure Chemical Industries (Osaka, Japan). Tryptic soy agar 5 
and thioglycollate medium were purchased from EIKEN Chemical (Tokyo, Japan). 5- or 6 
6-(N-succinimidyloxycarbonyl)-fluorescein 3ʹ′, 6ʹ′-diacetate (CFSE) and Bacstain CTC 7 
(5-cyano-2, 3-ditolyl-2H-tetrazolium chloride) Rapid Staining kit were purchased from 8 
DOJINDO (Kumamoto, Japan). Cycloheximide (CHX) and a protease inhibitor cocktail 9 
were purchased from Nacalai Tesque (Kyoto, Japan). Polystyrene microspheres (1 µm 10 
in diameter) were obtained from Polysciences (Warrington, PA). EZ-DetectTM Rac1 11 
activation kit and EZ-DetectTM Cdc42 activation kit were purchased from Pierce 12 
Chemical (Rockford, IL). Recombinant mouse M-CSF was purchased from R&D 13 
Systems (Minneapolis, MN). 14 
 15 
Antibodies	 16 
Alexa Fluor 594-conjugated anti-rabbit IgG antibody (Ab) and Alexa Fluor 350-17 
conjugated anti-rabbit IgG Ab were purchased from Invivogen (San Diego, CA, USA). 18 
Anti-TLR2 monoclonal Ab (mAb, T2.5, mouse IgG1), FITC-conjugated anti-mouse 19 
TLR2 mAb (6C2, rat IgG2b), PE-conjugated anti-F4/80 mAb (BM8, rat IgG2a) and 20 
isotype-matched control mAbs (rat IgG2b and rat IgG2a) were obtained from 21 
eBioscience (San Diego, CA, USA). Affinity-purified mouse IgG was purchased from 22 
Jackson ImmunoResearch Laboratories (West Grove, PA) and used as a control IgG for 23 
anti-TLR2 mAb (T2.5). Rabbit anti-Listeria polyclonal Ab (IgG) was purchased from 24 
 7 
VivoStat (Alleroed, Denmark). Rabbit anti-Akt polyclonal Ab (IgG) and rabbit anti-1 
phosphorylated Akt mAb (IgG2b) were purchased from Cell Signaling Technology 2 
(Tokyo Japan). Anti-Rac1 mAb (mouse IgG2b) and anti-Cdc42 mAb (mouse IgG1) 3 
were obtained from Pierce (Rockford, IL, USA). Rat anti-mouse CD16/CD32 mAb 4 
(2.4G2, rat IgG2b) which specifically recognizes mouse FcγIII (CD16) and FcγII 5 
(CD32) receptors was obtained from BD Biosciences (Tokyo, Japan). 6 
 7 
Animals used in this study 8 
Wild-type female C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). 9 
TLR2–/–, TLR4–/– and MyD88–/– mice on a C57BL/6 background were purchased from 10 
Oriental Bioservice (Kyoto, Japan). All mice were maintained in specific-pathogen-free 11 
conditions and used at 7 to 10 weeks of age. The Animal Ethics and Research 12 
Committee of Kyoto University Graduate School of Medicine (Kyoto, Japan) approved 13 
all of the experimental procedures performed. 14 
 15 
Bacterial strains used in this study 16 
Listeria monocytogenes (LM) strain EGD was grown overnight in brain heart infusion 17 
(BHI) broth (EIKEN Chemical, Tokyo, Japan) at 37°C with shaking. One volume of the 18 
bacterial suspension was added to one hundred volumes of fresh BHI broth and LM was 19 
cultured for 5 h. After being washed, bacteria were suspended in phosphate-buffered 20 
saline (PBS) supplemented with 10% glycerol and stored at −80°C in aliquots. The 21 
concentration of bacteria was determined by plating 10-fold serially diluted suspensions 22 
on tryptic soy agar plates and counting the number of colonies 24 h after incubation. 23 
 24 
 8 
Enumeration of associating LM and LM phagocytosed by macrophages 1 
C57BL/6 WT, TLR2–/–, TLR4–/– and MyD88–/– mice were injected intraperitoneally with 2 
3 ml of 3% thioglycollate medium. Peritoneal exudate cells (PECs) were collected four 3 
days later. Bone marrow cells were collected from tibiae of mice and cultured in 4 
RPMI1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 5 
5 µg ml-1 gentamicin and recombinant mouse M-CSF (100ng ml-1) for 7 days. After 6 
washing with RPMI1640 medium, adherent bone marrow-derived macrophages were 7 
collected.  Cells were seeded in a 48-well plate at 2.5 × 105 cells well–1 and incubated at 8 
37°C for 2 h in RPMI1640 medium supplemented with 10% FBS. After washing to 9 
remove nonadherent cells, adherent macrophages were infected with LM at a 10 
multiplicity of infection (MOI) of 20 at 37°C for 1 h in FBS-free RPMI1640 medium. 11 
To enumerate LM associating with macrophages, cells were washed thoroughly to 12 
remove non-associating bacteria and lysed in PBS containing 0.1% Triton X-100. The 13 
cell lysate was diluted with PBS and inoculated on tryptic soy agar plates. The colony 14 
forming unit (CFU) number was counted 24 h after incubation. To enumerate the 15 
internalized bacteria, macrophages were infected with LM as described above, washed 16 
and cultured for 30 min in the presence of 20 µg ml–1 gentamicin. Preliminary 17 
experiment showed that extracellular bacteria are completely killed by this antibiotic 18 
treatment. Cells were washed and lysed in PBS containing 0.1% Triton X-100. The 19 
CFU number in the cell lysate was determined. In some experiments, macrophages were 20 
treated with 40 µg ml–1 anti-TLR2 mAb, 20 µM LY294002, 100 µg ml–1 CHX or 40 ng 21 
ml–1 C. difficile toxin B for 1 h, and infected with LM. Alternatively, WT, TLR2–/– and 22 
MyD88–/– macrophages were infected with LM at a MOI of 20 for 1 h in the presence of 23 
100 ng ml–1 LPS (TLR4 ligand) or 100 ng ml–1 Pam3CSK4 (TLR2 ligand) and the 24 
 9 
number of internalized LM was evaluated. Results were expressed as the relative 1 
phagocytic index which was calculated using the following formula: phagocytic index = 2 
(the number of phagocytosed LM / the number of associating LM) × 100. 3 
 4 
Discrimination between adherent and phagocytosed LM by immunofluorescence 5 
microscopy 6 
LM was labeled with 1 µg ml–1 CFSE for 15 min at room temperature with gentle 7 
shaking in the dark. Bacteria were washed twice with PBS and suspended in RPMI 8 
1640 medium. PECs obtained from WT, TLR2–/– and MyD88–/– mice were seeded at 2 × 9 
105 cells well–1 in a 24-well plate in which a 12 mm glass cover slip was placed in each 10 
well and washed 2 h after incubation to remove nonadherent cells. Adherent 11 
macrophages were infected with CFSE-labeled LM for 1 h, washed and fixed with PBS 12 
containing 1% paraformaldehyde for 5 min at room temperature. After confirming that 13 
the phagocytic efficiency was almost constant when cells were infected at a MOI of 20 14 
to 50, we infected macrophages with LM at MOI of 50 as this MOI enabled us to easily 15 
distinguish the associating bacteria from phagocytosed LM. To distinguish 16 
phagocytosed LM from adherent LM, infected cells were treated with rabbit anti-17 
Listeria Ab and Alexa Fluor 594-conjugated anti-rabbit IgG Ab to stain only the 18 
extracellular LM as described previously (22). The number of associating LM and 19 
adherent LM to macrophages were counted under a fluorescent microscope. 20 
Phagocytosed LM was enumerated using the following equation: the number of 21 
phagocytosed LM = the number of associating LM – the number of adherent LM. In 22 
addition, macrophages were incubated with polystyrene microspheres for 2 h at a bead 23 
to cell ratio of 50 to 1, and the phagocytic activity was evaluated. 24 
 10 
 1 
Viability of phagocytosed LM in macrophages 2 
Based on our preliminary finding that only the viable LM is able to convert CTC into 3 
fluorescent insoluble formazan, we employed the CTC staining kit to distinguish viable 4 
cells of LM from dead LM inside macrophages. To estimate the viability of 5 
phagocytosed LM in macrophages, therefore, PECs from WT, TLR2–/– and MyD88–/– 6 
mice were infected with CFSE-labeled LM at a MOI of 50 for 1 h. After washing, cells 7 
were incubated with CTC for 15 min to stain LM associating with macrophages. Cells 8 
were washed and fixed in PBS containing 1% paraformaldehyde. The extracellular LM 9 
was then stained with rabbit anti-Listeria Ab and Alexa Fluor 350-conjugated anti-10 
rabbit IgG Ab. The number of viable and dead bacteria phagocytosed in macrophages 11 
was counted under a fluorescence microscope. The viability of LM (%) was calculated 12 
as follows: the number of viable LM/ total number of phagocytosed LM × 100. 13 
 14 
Flow cytometric analysis 15 
Peritoneal exudate macrophages (1 × 106 cells) were prepared and treated with anti-16 
mouse CD16/CD32 mAb to block nonspecific binding to Fc receptor. In some 17 
experiment, peritoneal exudate macrophages were incubated for 1 h with 20 µM 18 
LY294002 or 40 ng ml–1 toxin B before treatment with anti-mouse CD16/CD32 mAb. 19 
Cells were stained with anti-TLR2 mAb (6C2) at a concentration of 0.5 µg ml–1 for 30 20 
min on ice and analyzed on a FACScalibur flow cytometer using the CELL Quest 21 
software (Becton Dickinson, Tokyo, Japan) (18). To determine the percentage of 22 
macrophages in PECs of WT, TLR2–/– and MyD88–/– mice, PECs were collected, stained 23 
with PE-conjugated anti-F4/80 mAb and analyzed by flow cytometry.  24 
 11 
 1 
Determination of phosphatidylinositol 3-kinase (PI3K) activity by detection of 2 
phosphorylated Akt 3 
Akt is a downstream substrate of PI3K and phosphorylation of Akt can be used as a 4 
marker of PI3K activation (2). Thus, we analyzed the amount of phosphorylated Akt 5 
semi-quantitatively by Western blotting. Peritoneal exudate macrophages were prepared 6 
at 1 × 106 cells well–1 in a 24-well culture plate and infected with LM (MOI=20) for 15 7 
and 30 min. The cells were lysed in 100 µl of 2 × SDS sample buffer containing a 8 
protease inhibitor cocktail. The cell lysate was sonicated for 5 min, boiled for 2 min and 9 
then subjected to 10% SDS-polyacrylamide gel electrophoresis. The proteins were 10 
electroblotted to PVDF membrane. The membrane was incubated with rabbit anti-Akt 11 
Ab or rabbit anti-phosphorylated Akt mAb for 1 h, and anti-rabbit IgG Ab conjugated 12 
with horseradish peroxidase. After treatment with Enhanced Chemiluminescence (ECL) 13 
Detection Reagents (Millipore, Billerica, MA, USA), the bands representative of Akt 14 
and phosphorylated Akt were detected using LAS-4000 mini Fuji film (Tokyo, Japan). 15 
 16 
Determination of Rac1 and Cdc42 activation in LM-infected macrophages  17 
Activated Rac1 and Cdc42 were detected using an EZ-DetectTM Rac1 and Cdc42 18 
activation kits. Briefly, peritoneal exudate macrophages were prepared at 2 × 106 cells 19 
well–1 in a 24-well culture plate and infected with LM (MOI=20) for 15 and 30 min. The 20 
cells were lysed in a lysis/binding/wash buffer (Pierce) containing a protease inhibitor 21 
cocktail and the supernatant was collected after centrifugation (16,000 × g) at 4°C for 22 
15 min. Activated Rac1 and Cdc42 were precipitated with GST-human Pak1-PBD and 23 




Phagocytosis of LM by macrophages during in vivo infection 3 
WT, TLR2–/– and MyD88–/– mice were injected intraperitoneally (i.p.) with 3 ml of 3% 4 
thioglycollate medium and infected i.p. with 1 × 108 CFU of LM 4 days later. PECs 5 
were harvested 5 min after infection, washed and cultured in RPMI1640 medium 6 
containing gentamicin for 30 min to kill extracellular LM. Cells were washed and lysed 7 
by 0.1% Triton X-100. The number of phagocytosed LM was determined as described 8 
above. Alternatively, WT and TLR2–/– mice were injected intravenously (i.v.) with 104 9 
CFU of LM. Spleen was collected 1 day after infection and homogenized in PBS. The 10 
number of viable bacteria in the homogenates was determined. 11 
 12 
Statistical analysis 13 
The statistical significance of the data was determined using a two-tailed Student’s t-test. 14 
A P value of < 0.05 was considered statistically significant. All data represent the results 15 
of two to three independent experiments. 16 
 17 
Results 18 
TLR2, but not TLR4, is involved in the phagocytosis of LM by macrophages 19 
To analyze the role of TLR2 in the phagocytosis of LM, we infected macrophages with 20 
LM (5 × 106 CFU) in the presence or absence of anti-TLR2 mAb and determined the 21 
number of internalized bacteria using the gentamicin protection assay. As shown in 22 
Figure 1A, WT macrophages were able to phagocytose about 5 × 105 CFU of LM, 23 
which was equivalent to 10% of the total bacteria added to the culture. Treatment with 24 
 13 
anti-TLR2 mAb significantly reduced the number of internalized bacteria while mouse 1 
IgG, used as a control, did not affect the ability of macrophages to phagocytose bacteria 2 
(Fig. 1A). To confirm the involvement of TLR2 in the phagocytosis of LM, 3 
macrophages from WT, TLR2–/– and TLR4-deficient (TLR4–/–) mice were compared. As 4 
expected, the phagocytic ability of TLR2–/– macrophages was significantly lower than 5 
that of WT macrophages (Fig. 1B). On the other hand, TLR4–/– macrophages did not 6 
show any defect in phagocytic ability compared with WT macrophages. As TLR2 has 7 
been shown to recognize components of LM (39), it is postulated that TLR2 serves as a 8 
phagocytic receptor that traps LM directly on macrophages. Alternatively, the 9 
intracellular signaling that is triggered by recognition of LM by TLR2 may be critical 10 
for the phagocytosis of LM. To investigate this, we infected WT and TLR2–/– 11 
macrophages with LM and determined the number of both LM associating with 12 
macrophages and phagocytosed bacteria. There was no difference in the number of 13 
associating LM between WT and TLR2–/– macrophages, indicating that the bacterium 14 
adhered to macrophages irrespective of the expression of TLR2 (Fig. 1C). On the other 15 
hand, WT macrophages phagocytosed about 55 % of LM out of all associating bacteria; 16 
and TLR2–/– macrophages exhibited a significantly lower phagocytic index (Fig. 1D). 17 
When bone marrow-derived macrophages (BMDM) were used, a similar difference was 18 
observed between WT BMDM and TLR2–/– BMDM (Fig. 1E). To rule out the 19 
possibility of a general impairment in phagocytic ability, we analyzed the internalization 20 
of polystyrene beads, which is not dependent on any TLRs. As shown in Figure 1F, the 21 
internalization of polystyrene beads was found to be identical in WT and TLR2–/– 22 
macrophages. These results showed that TLR2, but not TLR4, might play a role in the 23 
phagocytosis of LM by macrophages.   24 
 14 
 1 
To further confirm the involvement of TLR2 in the phagocytosis of LM, the phagocytic 2 
efficiency was assessed by fluorescence microscopy.  We infected WT and TLR2–/– 3 
macrophages with CFSE-labeled LM. Cells were then treated with rabbit anti-Listeria 4 
Ab and Alexa Fluor 594-conjugated anti-rabbit IgG Ab. This procedure enabled us to 5 
distinguish internalized bacteria from bacteria adhering to the surface of macrophages 6 
under fluorescence microscope (Fig. 2A). The efficiency of phagocytosis was 7 
determined in 500 infected macrophages. As being similar to Fig. 1C, there was no 8 
difference in the total number of associating LM between WT and TLR2–/– macrophages 9 
(Fig. 2B). On the other hand, WT macrophages exhibited a higher phagocytic activity 10 
than TLR2–/– macrophages. The phagocytic index was found to be significantly lower in 11 
TLR2–/– macrophages compared to that of WT (Fig. 2C). We further compared the 12 
phagocytic efficiency of individual macrophages between the two groups. The results 13 
depicted in Figure 2D illustrating the number of macrophages grouped according to 14 
their phagocytic index in WT and TLR2–/– macrophages, clearly shows that most of the 15 
WT macrophages had a higher phagocytic index whereas most of the TLR2–/– 16 
macrophages had a lower phagocytic index. Furthermore, it is probable that the 17 
difference in the phagocytic efficiency between WT and TLR2–/– macrophages might be 18 
attributable to the bactericidal activity of these macrophages. To test the hypothesis, the 19 
viability of LM inside macrophages was measured after 1 h of phagocytosis. We found 20 
that most of the bacteria inside WT and TLR2–/– macrophages were viable and there was 21 
no significant difference in the viability between these two groups (Fig. 2E). These 22 
results indicated that TLR2 participates in the enhancement of the basic phagocytosis of 23 
LM by macrophages while TLR2 itself does not participate in the direct adhesion of LM. 24 
 15 
  1 
MyD88 is required for efficient TLR2-dependent phagocytosis of LM 2 
We next investigated whether TLR2-dependent signaling is required for phagocytosis of 3 
LM. As MyD88 is an essential adaptor protein for TLR2-dependent signaling, we 4 
examined the phagocytic ability of macrophages from MyD88–/– mice. As shown in 5 
Figure 3A, the number of phagocytosed LM in MyD88–/– macrophages was 6 
significantly lower than that in WT macrophages. In addition, fluorescence microscopy 7 
revealed that MyD88–/– macrophages had a significantly lower phagocytic index 8 
compared with WT macrophages (Fig. 3B). The absence of any reduction in the 9 
phagocytosis of polystyrene beads supported that the view that the effect seen in 10 
MyD88–/– macrophages was not due to some general impairment of macrophage 11 
function (Fig. 3C). In addition, we found that there was no difference in the viability of 12 
bacteria in WT and MyD88–/– macrophages. The majority of phagocytosed bacteria were 13 
viable in two groups of macrophages (Fig. 3D). These results indicated that TLR2- and 14 
MyD88-dependent signaling enhanced the phagocytosis of LM by macrophages. To rule 15 
out the possibility that the reduced phagocytosis of LM observed in MyD88–/– 16 
macrophages is due to the reduced expression of TLR2, we carried out FACS analysis 17 
to analyze the expression level of TLR2 on these macrophages. As shown in Figure 3E, 18 
TLR2 was expressed on WT but not TLR2–/– macrophages. In MyD88–/– macrophages, 19 
the expression level of TLR2 was slightly reduced but a substantial expression was 20 
detected. In addition, we determined the percentage of macrophages in whole and 21 
adherent PECs of WT, TLR2–/– and MyD88–/– mice by measuring the number of F4/80-22 
positive cells. There was no difference in the purity of macrophages in whole and 23 
adherent PECs of these mice (Fig. 3F). From these findings, it was clear that the 24 
 16 
reduced phagocytic efficiency in MyD88–/– macrophages was not due to the reduced 1 
expression of the extracellular domain of TLR2, a general impairment in phagocytosis 2 
or a difference in bactericidal activity. It was also clear that the TLR-MyD88 signaling 3 
pathway plays a potentially important role in intracellular engulfment of bacteria 4 
adhering to the macrophage surface.  5 
 6 
Involvement of downstream signaling from TLR-MyD88 but not cytokine/other gene 7 
expression in phagocytosis of LM by macrophages 8 
LPS is known to stimulate the cytokine response through TLR4-MyD88-dependent 9 
signaling pathway. To confirm the importance of the MyD88-dependent signaling 10 
pathway, we tested whether stimulation with LPS restores the level of LM phagocytosis 11 
in TLR2–/– or MyD88–/– macrophages to WT levels. WT, TLR2–/– and MyD88–/– 12 
macrophages were infected with LM in the presence or absence of LPS or Pam3CSK4 13 
(an authentic TLR2 ligand), and the efficiency of phagocytosis was examined. The 14 
phagocytic ability of WT macrophages was not influenced by treatment with either 15 
Pam3CSK4 or LPS. Again, TLR2–/– macrophages exhibited a decrease in the phagocytic 16 
index compared with WT macrophages, as shown previously. However, the reduced 17 
phagocytic ability of TLR2–/– macrophages was significantly increased by treatment 18 
with LPS, while Pam3CSK4 did not show such an enhancing effect (Fig. 4A). On the 19 
other hand, treatment with LPS never enhanced the phagocytic efficiency of MyD88–/– 20 
macrophages (Fig. 4B). These results strongly suggested that activation of the MyD88-21 
dependent signaling pathway is required for the enhancement of basic phagocytosis of 22 
LM by macrophages. 23 
 24 
 17 
It has been shown that activation of the TLR2 signaling pathway induces the production 1 
of cytokines, including tumor necrosis factor-α (TNF-α) that causes macrophage 2 
activation. Doyle et al. (13) recently reported that stimulation of macrophages with TLR 3 
ligands induces the expression of several scavenger receptors that serve as phagocytic 4 
receptors. Therefore, it could be postulated that signals downstream of the TLR-MyD88 5 
pathway, leading to expression of cytokines or some phagocytic receptors after LM 6 
infection, might contribute to phagocytosis. To test this, we determined the effect of 7 
CHX on phagocytosis. CHX treatment mostly inhibited the production of IL-6 and 8 
TNF-α from infected macrophages, whereas cell viability was not affected (data not 9 
shown). We found that CHX treatment did not alter the number of phagocytosed 10 
bacteria by WT and TLR2–/– macrophages (Fig. 4C), suggesting that the phagocytosis of 11 
LM is independent of protein synthesis and that TLR2-dependent enhancement of 12 
phagocytosis is not due to cytokine production or expression of phagocytic receptors. 13 
 14 
Phosphatidylinositol 3-kinase (PI3K) is implicated in TLR2-dependent enhancement of 15 
phagocytosis of LM 16 
Phagocytosis of bacteria requires the activation of a number of signaling pathways that 17 
regulate the rearrangement of the actin cytoskeleton and extension of the plasma 18 
membrane (54). It has been shown that PI3K plays an important role in phagocytosis 19 
and TLR-dependent signaling induces activation of PI3K (32). These findings prompted 20 
us to determine whether PI3K contributes to the TLR2-dependent phagocytosis of LM. 21 
We infected WT, TLR2–/– and MyD88–/– macrophages with LM in the presence or 22 
absence of LY294002, a PI3K inhibitor, and measured the number of phagocytosed 23 
bacteria. In WT macrophages, PI3K inhibitor reduced the efficiency of phagocytosis in 24 
 18 
a dose dependent manner (Fig. 5A). We found that treatment of WT macrophages with 1 
LY294002 decreased the number of phagocytosed bacteria to almost the basal level 2 
observed in TLR2–/– and MyD88–/– macrophages. However, the inhibitor did not affect 3 
the phagocytosis by TLR2–/– and MyD88–/– macrophages (Fig. 5B). To confirm whether 4 
activation of PI3K is actually induced in infected macrophages, we analyzed the amount 5 
of phosphorylated Akt, one of the substrates of PI3K known to be an important 6 
signaling molecule for the induction of phagocytosis (2). During infection of WT 7 
macrophages with LM, the amount of phosphorylated Akt (pAKT) was increased 30 8 
min after infection. However, no increase in pAKT was detected in TLR2–/– and 9 
MyD88–/– macrophages (Fig. 5C). These results indicated that LM-induced TLR2 10 
signaling enhances phagocytosis through activation of PI3K and Akt phosphorylation. 11 
 12 
Rac1 but not Cdc42 activation is important for the phagocytosis of LM by macrophages 13 
PI3K signaling has been reported to play an important role in actin polymerization 14 
through activation of the Rho family of GTPases that subsequently recruit the Arp2/3 15 
complex to form the actin nucleation (7). In order to determine the possible involvement 16 
of these Rho family GTPases in the PI3K-directed actin polymerization during 17 
phagocytosis of LM, we tested the effect of C. difficile toxin B, an inhibitor specific for 18 
the Rho family GTPases (9, 30). We infected WT, TLR2–/– and MyD88–/– macrophages 19 
with LM in the presence or absence of toxin B, and measured the number of 20 
phagocytosed bacteria. In WT macrophages, toxin B markedly reduced the efficiency of 21 
phagocytosis but did not affect phagocytosis by TLR2–/– and MyD88–/– macrophages 22 
(Fig. 6A). We also examined whether Rac1 activation is induced in infected 23 
macrophages by analyzing the activated GTP-bound form of Rac1 or Cdc42. According 24 
 19 
to Western blot analysis (Fig. 6B), an increased level of GTP-bound Rac1 was detected 1 
30 min after infection in WT macrophages whereas it was almost undetectable in 2 
TLR2–/– and MyD88–/– macrophages. Cdc42 did not appear to be involved in the process 3 
because there was no difference in the levels of GTP-bound Cdc42 between WT 4 
macrophages and TLR2–/– or MyD88–/– macrophages. In addition, the expression level 5 
of TLR2 on WT, TLR2–/– and MyD88–/– macrophages was not affected by treatment 6 
with LY294002 or toxin B (Fig. 7). Taken together, these results indicated that LM-7 
induced TLR2-MyD88 signaling enhances the phagocytosis through activation of PI3K 8 
and Rac1.  9 
 10 
TLR-MyD88 signaling is important for the phagocytosis during LM infection in vivo 11 
In order to confirm the biological significance of our in vitro data during LM infection 12 
in vivo, we compared the number of phagocytosed bacteria in WT, TLR2–/– and 13 
MyD88–/– mice i.p. infected with LM. As shown in Figure 8A, the number of LM 14 
entrapped by a given number of macrophages recovered after i.p. infection was 15 
significantly lower in TLR2–/– and MyD88–/– mice as compared with the macrophages 16 
from WT mice. It has been shown that LM is captured mainly by various types of 17 
macrophages in the periarteriolar lymphoid sheath within 24 h after infection (4).  18 
Therefore, we intravenously infected WT and TLR2–/– mice with LM and the CFU 19 
number in spleen were enumerated 1 day later. The CFU number in spleen of TLR2–/– 20 
mice was approximately 4 times as low as that of WT mice (0.5 × 105 CFU Vs 1.9 × 105 21 
CFU, respectively) (Fig. 8B). Thereafter, LM replicated similarly in spleens of both WT 22 
and TLR2–/– mice and the CFU number reached at 1 × 107 CFU in WT and 0.8 × 107 23 
CFU in TLR2–/– mice 3 days after infection. These results suggest that the TLR2-24 
 20 
dependent signaling actually contributes to the phagocytosis of macrophages in vivo and 1 
the phagocytic activity of TLR2–/– macrophages might result in the lower bacterial 2 
burden within 1 day after LM infection whereas the difference in the phagocytic activity 3 
did not affect the final bacterial growth at the late phase of infection.  4 
 5 
Discussion 6 
Increasing evidences indicate that TLR-dependent signaling promotes not only cytokine 7 
production but also phagocytosis of bacteria by macrophages. The effect of TLR on 8 
phagocytosis of some extracellular bacteria has previously been reported (6, 13, 35). 9 
TLR2 expressed on macrophages plays a key role in the cellular response to 10 
components of Gram-positive bacteria including LM (28, 36). However, there have 11 
been no reports to date showing that TLR2 signaling is involved in the phagocytosis of 12 
LM by macrophages. The results obtained in this study have clearly shown that 13 
although LM is able to invade macrophages independently of TLR2 and MyD88, TLR2 14 
but not TLR4, enhances the basic level of phagocytosis of LM by macrophages. 15 
 16 
It has been shown that intracellular parasitic bacteria are capable of modulating the 17 
bactericidal activity of macrophages in order to grow and reside in infected cells. LM is 18 
known to survive inside macrophages by escaping from phagosomes into the cytosol 19 
before phagolysosome formation takes place. However, Alvarez-Dominguez et al. (3) 20 
and Henry et al. (23) suggested that virulent LM has the ability to delay phagosome 21 
maturation. Although it has not yet been elucidated how LM directly manipulates the 22 
bactericidal mechanism of professional phagocytes, it is clear that LM has the potential 23 
to modulate the intracellular killing mechanism. Therefore, we determined the 24 
 21 
contribution of TLR2 signaling in the phagocytosis of LM by macrophages. Here we 1 
have shown that peritoneal macrophages from TLR2–/– and MyD88–/– have markedly 2 
reduced phagocytic efficiency compared with WT macrophages. A similar reduction 3 
was observed in bone marrow-derived macrophages from these knockout mice although 4 
the number of phagocytosed LM were 5-fold lower than peritoneal macrophages (data 5 
not shown). Therefore it is clear that the TLR2-MyD88-dependent signaling pathway is 6 
critical for the efficient phagocytosis of LM. 7 
 8 
Doyle et al. (13) showed that pretreatment with TLR ligands enhances phagocytosis by 9 
macrophages due to up-regulation of specific phagocytic receptors such as scavenger 10 
receptors, including scavenger receptor-A (SR-A), a macrophage receptor with a 11 
collagenous structure (MARCO). However, in our experiments, the difference in the 12 
efficiency of phagocytosis between WT and TLR2–/– macrophages could be observed as 13 
early as 1 h after infection. In addition, treatment with CHX did not affect the levels of 14 
phagocytosis in WT and TLR2–/– macrophages. Although any level of contribution of 15 
known phagocytic receptors that are constitutively expressed cannot be completely 16 
excluded, these results strongly imply that TLR2-dependent enhancement of 17 
phagocytosis of LM is not simply due to the production of cytokines or expression of 18 
phagocytic receptors such as scavenger receptors after LM infection.  19 
 20 
In studying the possible mechanism involved in the TLR-mediated enhanced 21 
phagocytosis of LM by macrophages, fluorescence microscopy was useful in 22 
distinguishing LM outside or inside the macrophages. From our findings, TLR2 is 23 
unlikely acting as a phagocytic receptor that directly captures LM on macrophage 24 
 22 
surfaces. Shin et al. (48) have shown that signaling through TLR adaptor MyD88 plays 1 
an important role in the uptake of Borrelia. Our results showing the reduced efficiency 2 
of phagocytosis in MyD88–/– macrophages suggested a similar role of TLR-MyD88 3 
signaling in phagocytosis of LM by macrophages. Moreover, the restoration of reduced 4 
phagocytosis in TLR2–/– but not MyD88–/– macrophages by addition of the TLR4 ligand 5 
LPS confirmed the importance of downstream signaling through MyD88 in the 6 
enhancement of phagocytosis.  7 
 8 
MyD88 is an adaptor protein involved in a variety of downstream signaling pathways (1, 9 
41), and some reports have suggested the link between PI3 kinases and phagocytosis 10 
(49, 54). PI3K catalyzes the phosphorylation of several species of phosphatidylinositol 11 
that are important in recruiting signaling molecules such as Akt/PKB to specific regions 12 
of the membrane. It is also involved in membrane extension, fusion behind bound 13 
particles and insertion of new membrane at the site of particle internalization (54). 14 
Recent studies have shown that PI3K is involved in the induction of TLR-mediated 15 
cellular responses including uptake of TLR ligands and cytokine production (32, 50). In 16 
our study we found that preincubation with LY294002, a PI3K inhibitor, resulted in 17 
impaired phagocytosis of LM by WT macrophages in a dose dependent manner. 18 
However, treatment with p38 and ERK inhibitors did not result in a reduction in 19 
phagocytosis of LM by macrophages (data not shown). Furthermore, there was a 20 
significant difference in the magnitude of PI3K activation between WT and TLR2–/– or 21 
MyD88–/– macrophages after LM infection indicating that PI3K is critically involved in 22 
the downstream signaling pathway during phagocytosis of LM by WT macrophages. 23 
 24 
 23 
The Rho GTPases, Rac1 and Cdc42, are widely known as the critical regulators of actin 1 
cytoskeletal rearrangements during the phagocytic response to a variety of extracellular 2 
stimuli (10, 12). It has been reported that PI3K signaling is involved in the activation of 3 
the Rho family GTPases, including Rac1 and Cdc42, leading to the initiation of actin 4 
polymerization (21). In our study, we found that inhibition of the Rho family GTPases 5 
by toxin B reduced phagocytosis of LM and that activation of Rac1, but not Cdc42, was 6 
far less significant in TLR2–/– and MyD88–/– macrophages. In addition, the inhibitors for 7 
PI3k and Rac1 never affected the expression of TLR2 on macrophages. Therefore it is 8 
likely that TLR2-MyD88-mediates an enhancement of phagocytosis through PI3K and 9 
Rac1 activation in WT macrophages after infection with LM. This is consistent with the 10 
recent report by Shin et al. showing that downstream signaling of MyD88-mediated 11 
phagocytosis is dependent on PI3K and Rac1 activation during Borrelia infection (48). 12 
However, one recent study showed that a MyD88-independent activation of the actin-13 
Cdc42/Rac pathway is required for TLR mediated phagocytosis (30). In fact the authors 14 
determined the phagocytosis of GFP-E. coli after LPS treatment, which is different from 15 
our experiment that directly focuses on the role of TLR2 on early infection (after 1 h) 16 
without treatment. Furthermore, Braun et al. (8) reported that LM induces activation of 17 
PI3K to infect Caco-2 cells via InlB protein. Therefore, activation of PI3K appears to be 18 
important for the internalization of LM irrespective of the type of host cell. Small Rho 19 
GTPases are upstream activators of the Arp2/3 complex in many actin polymerization 20 
events such as cell–cell adhesion, cell movement and phagocytosis (28). Moreover, 21 
Sandra et al. (44) reported that Rac1 promotes recruitment of cortactin and activation of 22 
Arp2/3 in E-cadherin mediated Listeria entry. A possibility that Arp2/3 might be the 23 
 24 
downstream molecule for phagocytosis of LM by macrophages is to be determined in a 1 
further study.  2 
 3 
Although our results clearly indicate that TLR2-MyD88-dependent signals leading to 4 
PI3K and Rac1 activation enhance the phagocytosis of LM by macrophages, the exact 5 
interaction between TLR2 and its ligand for the induction of the MyD88-PI3K-Rac1 6 
pathway still remains to be determined. Recent studies highlighted the immunological 7 
function of lipoproteins derived from Gram-positive bacteria and lipoproteins have been 8 
shown to induce the host immune response via activation of the TLR2 signaling 9 
pathway. Machata et al. (40) have shown that surface lipoproteins derived from LM 10 
activate the TLR2 signaling pathway during the early phase of infection. It is possible 11 
that the interaction of TLR2 with lipoprotein expressed on the surface of LM is 12 
involved in the TLR2-dependent enhancement of phagocytosis that was observed in our 13 
study. On the other hand, little is known about receptors that contribute to the 14 
phagocytosis of LM. It seems that one or more receptors, which are constitutively 15 
expressed on macrophages including type I and type II scavenger receptors, may serve 16 
as phagocytic receptors for LM (26). In this study, we found that CHX never affected 17 
TLR2-dependent phagocytosis. This result suggests that enhancement of the 18 
phagocytosis is not attributable to the newly synthesized phagocytic receptors after LM 19 
infection. The exact manner of direct interaction between macrophages and LM remains 20 
to be elucidated.  21 
 22 
There is increasing evidence suggesting the involvement of TLR signaling in 23 
phagocytosis of bacterial pathogens in vitro (41). However, the functional significance 24 
 25 
of these finding in vivo has yet to be determined in many cases. In the present study, we 1 
showed that macrophages from TLR2–/– and MyD88–/– mice harbor significantly lower 2 
numbers of phagocytosed LM after i.p. and i.v. infection with LM compared with 3 
macrophages from WT mice in the early period of LM infection. This finding clearly 4 
indicates that the TLR2-MyD88-mediated enhancement of phagocytosis is not a 5 
phenomenon observed only under specific experimental conditions in vitro but is also 6 
applicable to in vivo infection.  7 
 8 
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Figure Legends 1 
 2 
Figure 1. Difference in the phagocytosis of Listeria monocytogenes (LM) between 3 
WT and TLR2-/- macrophages. (A) WT macrophages were incubated with 40 µg ml–1 4 
anti-TLR2 mAb (IgG1) or mouse control IgG for 1 h, and infected with LM at a MOI of 5 
20 for 1 h. Cells were then treated with 20 µg ml–1 gentamicin for 30 min and the 6 
number of phagocytosed bacteria was enumerated. (B) WT, TLR2–/– and TLR4–/– 7 
macrophages were infected with LM at a MOI of 20 for 1 h. The number of 8 
phagocytosed bacteria was determined after treatment with gentamicin for 30 min. (C, 9 
D) WT and TLR2–/– macrophages were infected with LM as mentioned above and the 10 
number of associating-LM (C) and the mean phagocytic index (D) were determined. 11 
The mean phagocyte index was calculated as follows: (the number of phagocytosed 12 
LM/the number of associating LM) × 100. (E) Bone marrow-derived macrophages from 13 
WT and TLR2–/– macrophages were infected with LM at a MOI of 20 for 1 h and the 14 
number of phagocytosed bacteria was determined. (F) WT and TLR2–/– macrophages 15 
were cultured with polystyrene beads for 2 h at a bead to cell ratio of 50 to 1. After 16 
washing, cells were fixed with 1% paraformaldehyde and the number of internalized 17 
beads was counted under fluorescence microscope. Data are expressed as the mean ± 18 
SD for triplicate cultures. Similar results were obtained in three independent 19 
experiments. * P < 0.05.  20 
 21 
Figure 2. Fluorescence microscopic analysis for the phagocytosis of LM. (A) WT 22 
and TLR2–/– macrophages were cultured with CFSE-labeled LM at a MOI of 50 for 1 h. 23 
After washing, cells were fixed and incubated with rabbit anti-Listeria Ab and anti-24 
 35 
rabbit IgG Ab conjugated with Alexa Fluor 594 to stain adherent LM to macrophages. 1 
According to the procedure, phagocytosed LM (green spots) was distinguished from 2 
adherent LM (yellow spots) in merged fluorescence images. (B, C) After staining 3 
infected LM with rabbit anti-Listeria Ab and Alexa Fluor 594-conjugated anti-rabbit 4 
IgG Ab, the number of associating LM and adherent LM was counted in 500 WT and 5 
TLR2–/– macrophages, and the number of phagocytosed LM was determined. The 6 
phagocytic index was calculated as follows: phagocytic index (%) = (the number of 7 
phagocytosed LM/the number of associating LM) × 100. The average number of 8 
associating LM (B) and mean phagocyte index (C) are depicted. * P < 0.05. (D) 9 
Columns depict the exact distribution of the phagocytic index in WT and TLR2–/– 10 
macrophages. The experiment was repeated three times and data are expressed as the 11 
mean ± standard error for three independent experiments. (E) WT and TLR2–/– 12 
macrophages were infected with CFSE-labeled LM at a MOI of 50 for 1 h and 13 
incubated with CTC for 15 min. Cells were fixed and treated with rabbit anti-Listeria 14 
Ab and Alexa Fluor 350-conjugated anti-rabbit IgG Ab. The numbers of viable and dead 15 
bacteria inside macrophages were counted. The viability of intracellular bacteria (%) 16 
was calculated as follows: The number of viable LM/(the number of viable and dead 17 
LM) × 100.  18 
 19 
Figure 3. Difference in the phaogocytosis of LM between WT and MyD88–/– 20 
macrophages. (A) WT and MyD88–/– macrophages were infected with LM at a MOI of 21 
20 for 1 h. After washing, cells were treated with gentamicin for 30 min and the number 22 
of phagocytosed bacteria was determined. Data are expressed as the mean ± SD for 23 
triplicate cultures. Similar results were obtained in three independent experiments. * P < 24 
 36 
0.05. (B) WT and MyD88–/– macrophages were infected with CFSE-labeled LM at a 1 
MOI of 50 for 1 h. The number of phagocytosed LM and adherent LM was evaluated 2 
after immunostaining. Data are expressed as the means ± SD for triplicate cultures. 3 
Similar results were obtained in two independent experiments. * P < 0.05. (C) WT and 4 
MyD88–/– macrophages were incubated with polystyrene beads for 2 h. After washing, 5 
cells were fixed and the number of internalized beads was counted. (D) WT and 6 
MyD88–/– macrophages were infected with CFSE-labeled LM at a MOI of 50 for 1 h and 7 
treated similarly to Fig. 2E. The viability of intracellular bacteria (%) was calculated. (E) 8 
WT, TLR2–/– and MyD88–/– macrophages were stained with FITC-conjugated anti-TLR2 9 
mAb (IgG2b) or control IgG2b, and the level of TLR2 expression was analyzed by 10 
FACS. The histogram with the bold line shows the level of TLR2 expression on the 11 
three types of macrophages. The hatched area represents the basal fluorescent intensity 12 
in cells treated with control Ab. (F) Whole PEC and adherent PEC obtained from WT 13 
(red), TLR2–/– (blue) and MyD88–/– (green) mice were stained with PE-conjugated anti-14 
F4/80 mAb (IgG2a).  The expression of F4/80 was analyzed by FACS. The hatched area 15 
represents the basal fluorescent intensity in cells treated with control IgG2a.  16 
 17 
Figure 4. The effect of LPS and cycloheximide on the phagocytosis of LM by 18 
TLR2-/- and MyD88-/- macrophages. (A) WT and TLR2–/– macrophages were infected 19 
with LM at a MOI of 20 in the presence or absence of 100 ng ml–1 Pam3CSK4 or 100 20 
ng ml–1 LPS for 1 h, and the number of phagocytosed LM was determined. Data are 21 
expressed as the mean ± SD for triplicate cultures. * P < 0.05. (B) WT, TLR2–/– and 22 
MyD88–/– macrophages were infected with LM at a MOI of 20 in the presence or 23 
absence of 100 ng ml–1 LPS for 1 h, and the number of phagocytosed LM was counted. 24 
 37 
Data are expressed as the mean ± SD for triplicate cultures. * P < 0.05. (C) WT and 1 
TLR2–/– macrophages were infected with LM at a MOI of 20 for 1 h in the presence or 2 
absence of CHX, and the number of phagocytosed bacteria was determined. Data are 3 
expressed as the mean ± SD for triplicate cultures. Similar results were obtained in three 4 
independent experiments.  5 
 6 
Figure 5. The effect of LY294002 on the phagocytosis of LM and difference in the 7 
phosphorylation of Akt between WT, TLR2–/– and MyD88–/– macrophages after LM 8 
infection. (A) WT macrophages were infected with LM at a MOI of 20 in the presence 9 
of graded concentrations of LY294002, a PI3K inhibitor, and the number of 10 
phagocytosed bacteria was determined. Data are expressed as the mean ± SD for 11 
triplicate cultures. (B) WT, TLR2–/– and MyD88–/– macrophages were infected with LM 12 
at a MOI of 20 for 1 h in the presence or absence of 20 µM LY294002, and the number 13 
of phagocytosed bacteria was determined. Data are expressed as the mean ± SD for 14 
triplicate cultures. Similar results were obtained in two independent experiments. * P < 15 
0.05. (C) WT, TLR2–/– and MyD88–/– macrophages were infected with LM at a MOI of 16 
20 for 15 and 30 min. Cells were lysed and phosphorylated Akt was evaluated by 17 
Western blotting. Total Akt was used as a loading control. 18 
 19 
Figure 6. The effect of toxin B on the phagocytosis of LM and difference in the 20 
phosphorylation of Rho family GTPase proteins between WT, TLR2–/– and 21 
MyD88–/– macrophages after LM infection. (A) WT, TLR2–/– and MyD88–/– 22 
macrophages were infected with LM at a MOI of 20 for 1 h in the presence or absence 23 
of 40 ng ml–1 toxin B, and the number of phagocytosed bacteria was determined. Data 24 
 38 
are expressed as the mean ± SD for triplicate cultures. Similar results were obtained in 1 
two independent experiments. * P < 0.05. (B) WT, TLR2–/– and MyD88–/– macrophages 2 
were infected with LM at a MOI of 20 for 15 and 30 min. The GTP-bound forms of 3 
Rac1 and Cdc42 were precipitated using glutathione S-transferase (GST)-bound p21-4 
activated kinase 1 (PAK1) and quantified by Western blotting using anti-Cdc42 (IgG1) 5 
and anti-Rac1 (IgG2b) mAbs. Total Rac1 and Cdc42 in the cell lysate were used as a 6 
loading control. 7 
 8 
Figure 7. The effect of LY294002 and toxin B on the expression of TLR2 on 9 
macrophages. WT, TLR2–/– and MyD88–/– macrophages were incubated with 20 µM 10 
LY294002 or 40 ng ml–1 toxin B for 1 h and treated with anti-CD16/32 mAb (IgG2b), 11 
followed by staining with FITC-conjugated anti-TLR2 mAb (IgG2b) or control IgG2b. 12 
The level of TLR2 expression was analyzed by FACS. The histogram with the red line 13 
shows the level of TLR2 expression on macrophages without treatment, blue line 14 
represents the level of TLR2 expression on macrophages treated with LY294002, and 15 
green line shows the level of TLR2 expression on macrophages treated with toxin B. 16 
The hatched area represents the basal fluorescent intensity in cells treated with control 17 
IgG2b. 18 
 19 
Figure 8. Difference in the phagocytosis of LM and bacteria burden between WT 20 
and TLR2–/– mice after LM infection in vivo. (A) WT, TLR2–/– and MyD88–/– mice 21 
were injected i. p. with 3 ml of 3% thioglycollate medium and infected i. p. with 1 × 108 22 
CFU of LM 4 days later. Five min after infection, PECs were collected and the number 23 
of phagocytosed LM was determined. * P < 0.05. (B) WT and TLR2–/– mice were 24 
 39 
infected intravenously with 104 CFU of LM. Spleen was removed 1 day after infection 1 
and the number of viable bacteria in spleen was determined. * P < 0.05. 2 
 3 
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